# Study of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital

> **NCT07511361** · PHASE2 · RECRUITING · sponsor: **Kardigan, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Hypertension
- Acute Severe Hypertension

## Interventions

- **DRUG:** Tonlamarsen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07511361
- **Lead sponsor:** Kardigan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2026-12-29
- **Final completion:** 2027-02-23
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511361, "Study of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07511361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*